Comparison of the Effects of Deep and Moderate Neuromuscular Blockade on Optic Nerve Sheath Diameter

NCT ID: NCT04211064

Last Updated: 2021-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-30

Study Completion Date

2022-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Increased intracranial pressure (IICP) is a common problem in traumatic brain injuries and many medical diseases. Early recognition of IICP can save lives. Several invasive and non-invasive methods have been described for IICP diagnosis. In recent years, ultrasonographic measurement of optic nerve sheath diameter (ONSD) has become a popular method due to its high sensitivity and specificity for IICP estimation. Studies have shown that ONSD's ultrasonographic measurement correlates with the IICP and can detect intracranial hypertension. The ONSD measurement has advantages such as being easily applied by the clinician at the bedside, being non-invasive, providing immediate results, reproducibility and low cost. It is known that artificial carbon dioxide pneumoperitoneum created in laparoscopic surgeries increases intracranial pressure.However, it is not easy to estimate the degree of changes in ICP during laparoscopic surgery under general anesthesia. In the literature, there are many studies on the sonographic measurement of optic nerve sheath diameter to evaluate the effects of trendelenburg position on intracranial pressure with the use of different anesthetic drugs in laparoscopic surgeries. In addition, there are studies reporting that deep neuromuscular blockade in laparoscopic surgeries increases surgical vision and decreases analgesic requirement in postoperative period. The relationship between neuromuscular block level and intracranial pressure is not clear. From this point of view, the investigators would like to evaluate the effect of moderate and deep neuromuscular block level on intracranial pressure by sonographic measurement of optic nerve sheath diameter in laparoscopic cholecystectomy operations performed with standard pressure artificial carbon dioxide pneumoperitoneum.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be randomly divided into 2 groups. In the first group (Group 1), patients undergoing intraabdominal insufflation pressure 12 mmHg and deep neuromuscular block (TOF -- PTC 1-5), in the second group (Group 2) patients undergoing intraabdominal insufflation pressure 12 mmHg and moderate neuromuscular block (TOF 1-3) It would be classified.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators
The participants were blinded to group allocation, as the measurements were performed after induction of general anesthesia. The investigator measuring the optic nerve sheath diameter was blinded to the group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Deep neuromuscular block

Patients undergoing deep neuromuscular blockade with rocuronium (TOF -- PTC 1-5)

Group Type OTHER

Ultrasonographic measurement of optic nerve sheath diameter

Intervention Type DIAGNOSTIC_TEST

Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Deep neuromuscular block

Intervention Type PROCEDURE

Deep neuromuscular block will be obtained via appropriate dose of rocuronium.

Moderate neuromuscular block

Patients undergoing moderate neuromuscular blockade with rocuronium (TOF 1-3)

Group Type ACTIVE_COMPARATOR

Ultrasonographic measurement of optic nerve sheath diameter

Intervention Type DIAGNOSTIC_TEST

Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Moderate neuromuscular block

Intervention Type PROCEDURE

Moderate neuromuscular block will be obtained via appropriate dose of rocuronium.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasonographic measurement of optic nerve sheath diameter

Optic nerve sheath diameter will be measured at both neuromuscular blocks level.

Intervention Type DIAGNOSTIC_TEST

Deep neuromuscular block

Deep neuromuscular block will be obtained via appropriate dose of rocuronium.

Intervention Type PROCEDURE

Moderate neuromuscular block

Moderate neuromuscular block will be obtained via appropriate dose of rocuronium.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18-65 years
* ASA I-II
* Patients undergoing elective laparoscopic cholecystectomy

Exclusion Criteria

* Intracranial hypertension
* Glaucoma
* Chronic obstructive pulmonary disease
* Pseudotumor cerebri
* Cerebral venous sinus thrombosis
* İntraoperative hemodynamic instability
* Mean arterial blood pressure\<65 mmHg
* Body mass index\> 35
* Asthma
* Kidney or liver problems
* Lupus
* Crohn's disease or ulcerative colitis
* Previously had any gastrointestinal bleeding
* Hypertension
* Peripheral arterial disease
* Angina, heart attacks, or mild or moderate heart failure
* Stroke
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bezmialem Vakif University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Serdar Yeşiltaş

Principle Investigator, Medical Doctor, Anesthesiology and Reanimation

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Serdar Yeşiltaş, Instructor

Role: PRINCIPAL_INVESTIGATOR

BEZMİALEM VAKIF UNIVERSITY

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Serdar Yeşiltaş, Instructor

Role: CONTACT

+905423632630

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

54022451-050.05.04-

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.